{{Drugbox
| IUPAC_name = [1-(cyclohexylmethyl)-1''H''-indol-3-yl](naphthalen-1-yl)methanone
| image = NE-CHMIMO.svg

<!--Clinical data-->
| tradename = 
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category = 
| legal_AU =
| legal_CA = Schedule II
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref =
| CAS_number = 1373876-11-9
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 
| ChemSpiderID      = 
| UNII = 
| smiles            = O=C(c1cccc2ccccc12)c3cn(CC4CCCCC4)c5ccccc35
| StdInChI          = 1S/C26H25NO/c28-26(23-15-8-12-20-11-4-5-13-21(20)23)24-18-27(17-19-9-2-1-3-10-19)25-16-7-6-14-22(24)25/h4-8,11-16,18-19H,1-3,9-10,17H2
| StdInChIKey       = HGJYPIZWMHHQKS-UHFFFAOYSA-N

<!--Chemical data-->
| C=26 | H=25 |N=1 | O=1
| molecular_weight = 
}}

'''NE-CHMIMO''' ('''CHM-018''') is an [[indole]]-based [[synthetic cannabinoid]] that is presumed to be a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and has been sold online as a [[designer drug]].<ref>{{cite journal | url=http://www.sciencedirect.com/science/article/pii/S0379073816302432 | title=Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative “NE-CHMIMO” using flash chromatography, GC-MS, IR and NMR spectroscopy | author1=Verena Angerer | author2=Philippe Bisel | author3=Bjoern Moosmann | author4=Folker Westphal | author5=Volker Auwärter | journal=Forensic Science International | date=June 2016 | doi=10.1016/j.forsciint.2016.05.031 | pmid=27297324}}</ref><ref>{{cite web | url=http://nsddb.eu/substance/576/ | title=NE-CHMIMO | publisher=New Synthetic Drugs Database}}</ref> NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation [[synthetic cannabinoid]] [[JWH-018]]. The corresponding cyclohexylmethyl derivative of [[JWH-081]] had also been reported several months earlier.<ref>{{cite journal | author1=Karen Blakey | url=http://www.sciencedirect.com/science/article/pii/S0379073815004879 | title=Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense | date=March 2016 | author2=Sue Boyd | author3=Sarah Atkinson | author4=Jenna Wolf | author5=Pim M. Slottje | author6=Katrina Goodchild | author7=Jenny McGowan | journal=Forensic Science International | volume=260 | pages=40–53 | doi=10.1016/j.forsciint.2015.12.001 | pmid=26795397}}</ref>

==See also==
{{columns-list|colwidth=25em|
* [[AB-CHMINACA]]
* [[ADB-CHMINACA]]
* [[PX-3|APP-CHMINACA]]
* [[FUB-018]]
* [[MDMB-CHMICA]]
* [[MDMB-CHMINACA]]
}}

==References==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Naphthoylindoles]]


{{cannabinoid-stub}}